| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Euan M. Wallace | Q37838983 |
| Stephen Tong | Q39182423 | ||
| P2093 | author name string | Henry G Burger | |
| P2860 | cites work | Betaglycan binds inhibin and can mediate functional antagonism of activin signalling | Q22253420 |
| TGF-beta signalling from cell membrane to nucleus through SMAD proteins | Q28131770 | ||
| Signal transduction by the TGF-beta superfamily | Q28201963 | ||
| Expression of the activin axis and neuronal rescue effects of recombinant activin A following hypoxic-ischemic brain injury in the infant rat. | Q30739816 | ||
| Feto-placental hypoxemia regulates the release of fetal activin A and prostaglandin E(2). | Q31837243 | ||
| Concentrations of inhibins and activin in women undergoing stimulation with recombinant follicle-stimulating hormone for in vitro fertilization treatment | Q31864765 | ||
| Malignant Sertoli cell tumors of the testis: a study of 13 examples of a neoplasm frequently misinterpreted as seminoma | Q34125776 | ||
| The inhibins and ovarian cancer | Q34307727 | ||
| Dimeric inhibin A as a marker for Down's syndrome in early pregnancy. | Q34375938 | ||
| Follicle-stimulating hormone levels on cycle day 3 are predictive of in vitro fertilization outcome. | Q34425426 | ||
| The tissue distribution of activin beta A- and beta B-subunit and follistatin messenger ribonucleic acids suggests multiple sites of action for the activin-follistatin system during human development | Q38307403 | ||
| Genetic, biochemical, and multimodal approaches to screening for ovarian cancer | Q40579707 | ||
| Follistatin-free activin A is not associated with preterm birth | Q40651851 | ||
| Preeclampsia: an endothelial cell disorder | Q41281924 | ||
| Activin is a nerve cell survival molecule | Q41736766 | ||
| Inhibin A and inhibin B in women with polycystic ovarian syndrome during treatment with FSH to induce mono-ovulation | Q42458292 | ||
| Differential patterns of inhibin secretion in response to gonadotrophin stimulation in normal men. | Q43572516 | ||
| Physiological and regulatory roles of activin A in late pregnancy | Q43672748 | ||
| Serum levels of inhibin B in men with different causes of spermatogenic failure | Q77857057 | ||
| Inhibin forms in serum from postmenopausal women with ovarian cancers | Q78092036 | ||
| Adenocarcinomas of various sites may exhibit immunoreactivity with anti-inhibin antibodies | Q78197470 | ||
| Activin betaA-subunit and activin receptors in human myometrium at term and during labour. | Q43711080 | ||
| Importance of FSH-releasing protein and inhibin in erythrodifferentiation | Q43959843 | ||
| Immuno- and bioactive inhibin and inhibin alpha-subunit expression in rat Leydig cell cultures | Q45299903 | ||
| Maternal serum activin A, inhibin A, and follistatin in pregnancies with appropriately grown and small-for-gestational-age fetuses classified by umbilical artery Doppler ultrasound | Q45713018 | ||
| Survival among U.S. women with invasive epithelial ovarian cancer | Q46264510 | ||
| Dimeric inhibin: a direct marker of ovarian aging. | Q47860824 | ||
| Inhibin B in seminal plasma: testicular origin and relationship to spermatogenesis. | Q47996398 | ||
| Inhibin production by Sertoli cell cultures | Q48879666 | ||
| Inhibin A and inhibin B reflect ovarian function in assisted reproduction but are less useful at predicting outcome | Q48921586 | ||
| Day 3 serum inhibin-B is predictive of assisted reproductive technologies outcome | Q48968963 | ||
| Prospectively measured levels of serum follicle-stimulating hormone, estradiol, and the dimeric inhibins during the menopausal transition in a population-based cohort of women | Q49072154 | ||
| Inhibin B response to EFORT is associated with the outcome of oocyte retrieval in the subsequent in vitro fertilization cycle. | Q50720535 | ||
| Maternal serum inhibin A concentrations in early pregnancy after IVF and embryo transfer reflect the corpus luteum contribution and pregnancy outcome. | Q50724029 | ||
| Measurements of serum müllerian inhibiting substance in the evaluation of children with nonpalpable gonads. | Q50955381 | ||
| The site of inhibin production in ovarian neoplasms. | Q50987153 | ||
| Combining inhibin A with existing second-trimester markers in maternal serum screening for Down's syndrome. | Q52868678 | ||
| Assessment of inhibin and p53 in granulosa cell tumors of the ovary. | Q53336913 | ||
| Inhibin-B: a likely candidate for the physiologically important form of inhibin in men. | Q53838638 | ||
| Progesterone, inhibin, and hCG multiple marker strategy to differentiate viable from nonviable pregnancies | Q57710159 | ||
| Monoclonal antibody based ELISAs for measurement of activins in biological fluids | Q60433349 | ||
| Corticotropin-releasing hormone, corticotropin-releasing hormone–binding protein, and activin A in maternal serum: Prediction of preterm delivery and response to glucocorticoids in women with symptoms of preterm labor | Q61843179 | ||
| Changes in Molecular Weight Forms of Inhibin A and Pro- C in Maternal Serum during Human Pregnancy | Q61847074 | ||
| Maternal serum total activin A and follistatin in pregnancy and parturition | Q61847087 | ||
| Evaluation of serum inhibin A as a surveillance marker after conservative management of tubal pregnancy | Q61847098 | ||
| Dimeric Inhibins in Amniotic Fluid, Maternal Serum, and Fetal Serum in Human Pregnancy | Q61847103 | ||
| Maternal serum inhibin-A and free beta-hCG concentrations in trisomy 21 pregnancies at 10 to 14 weeks of gestation | Q61847105 | ||
| Physiological relationships between inhibin B, follicle stimulating hormone secretion and spermatogenesis in normal men and response to gonadotrophin suppression by exogenous testosterone | Q61847107 | ||
| Serum inhibin, activin and follistatin in postmenopausal women with epithelial ovarian carcinoma | Q61925533 | ||
| Serum inhibin A and activin A are elevated prior to the onset of pre-eclampsia | Q63359752 | ||
| Activin A and inhibin A as possible endocrine markers for pre-eclampsia | Q63359790 | ||
| Source of circulating levels of inhibin A, pro alpha C-containing inhibins and activin A in early pregnancy | Q63359793 | ||
| Tribute to Patrick Steptoe: beginnings of laparoscopy | Q69312131 | ||
| Serum levels of inhibin in maternal and umbilical blood during pregnancy | Q70116855 | ||
| The radioimmunoassay of bovine and human follicular fluid and serum inhibin | Q70293117 | ||
| Elevated serum inhibin concentrations in postmenopausal women with ovarian tumors | Q70513446 | ||
| Elevated levels of maternal serum inhibin immunoreactivity in second trimester pregnancies affected by Down's syndrome | Q70643005 | ||
| Characterization of inhibin immunoreactivity in post-menopausal women with ovarian tumours | Q71254941 | ||
| Serum inhibin levels are lower in ectopic than intrauterine spontaneously conceived pregnancies | Q71446567 | ||
| Serum inhibin and disease status in women with ovarian granulosa cell tumors | Q71973986 | ||
| Inhibin and activin are demonstrable by immunohistochemistry in ovarian tumor tissue | Q72130975 | ||
| A prospective study of inhibin in granulosa cell tumors of the ovary | Q72801774 | ||
| Activin A, inhibin A, inhibin B and parturition: changes of maternal and cord serum levels according to the mode of delivery | Q73078551 | ||
| Multiple immunoreactive inhibin proteins in serum from postmenopausal women with epithelial ovarian cancer | Q73433382 | ||
| Sex cord-stromal tumors of the testis with entrapped germ cells: a lesion mimicking unclassified mixed germ cell sex cord-stromal tumors | Q73657815 | ||
| Serum inhibin B determination is predictive of successful testicular sperm extraction in men with non-obstructive azoospermia | Q74089757 | ||
| Maternal serum levels of dimeric inhibin A in pregnancies affected by trisomy 21 in the first trimester | Q74140538 | ||
| Serum inhibins A and B fall differentially as FSH rises in perimenopausal women | Q77130387 | ||
| Maternal serum inhibin A can predict pre-eclampsia | Q77507377 | ||
| Inhibin A and pro-alpha C inhibin in Down syndrome and normal pregnancies | Q77687932 | ||
| A longitudinal study of maternal serum inhibin-A, inhibin-B, activin-A, activin-AB, pro-alphaC and follistatin during pregnancy | Q77787870 | ||
| P433 | issue | 2 | |
| P304 | page(s) | 115-127 | |
| P577 | publication date | 2003-02-01 | |
| P1433 | published in | Clinical Endocrinology | Q15762781 |
| P1476 | title | Inhibins and activins: clinical advances in reproductive medicine | |
| P478 | volume | 58 |
| Q37566244 | Activin A as a marker of intrauterine infection in women with preterm prelabour rupture of membranes. |
| Q36248317 | Activin A: from sometime reproductive factor to genuine cytokine. |
| Q36090162 | Essential roles of inhibin beta A in mouse epididymal coiling. |
| Q35966481 | Fertility in female cancer survivors: pathophysiology, preservation and the role of ovarian reserve testing |
| Q44791649 | Fetal activin A: associations with labour, umbilical artery pH and neonatal outcome |
| Q44818655 | First trimester levels of inhibins and activin A in normal and failing pregnancies |
| Q35680612 | Hormone therapy and Alzheimer's disease: benefit or harm? |
| Q35674942 | Sexually dimorphic regulation of inhibin beta B in establishing gonadal vasculature in mice. |
Search more.